NovaQuest invests $20m in Israeli biopharma company Mileutis

Mileutis is in advanced stages of development in the U.S., EU, and Israel of an innovative product which addresses the main concern in the dairy industry: bovine mastitis.

21 October 2020•5 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles